Showing posts with label inhalers. Show all posts
Showing posts with label inhalers. Show all posts

Wednesday, 5 September 2012

Asthma treatment deemed too expensive


For most asthmatics avoiding allergens and using inhaled medications are enough to keep asthma under control. But for the minority with severe, persistent asthma, medication and lifestyle changes are not enough. Frequent hospital trips are almost inevitable and powerful steroids like prednisone, which can cause thinning bones, cataracts, depression and other debilitating side effects become a necessity.
Tim Elder who lives in America had to give up recreational basketball and resort to using a golf cart rather than walking the green because of his worsening asthma condition. The 56-year old also found his physical stamina at work challenged lifting heavy boxes multiple times a day was no longer possible.
“It certainly was a concern that if I didn’t find some way to change the situation, it would get worse over time and really impact the quality of my life,” said Mr Elder, who suffers from a severe form of adult onset asthma.
The promise of change came with a new procedure called bronchial thermoplasty, which works by delivering thermal energy to the airway wall, to reduce airway smooth muscle that typically is enlarged in asthma patients.
During the procedure, a doctor guides a bronchoscope into a patient’s airways. There it heats the lungs to 149 degrees Fahrenheit, cooler than a cup of coffee, but warm enough to shrink the smooth muscle in the airways, which swells during an asthma attack and restricts breathing. After the procedure the airways no longer are so prone to constricting, studies show. Asthma patients suffer fewer attacks and need fewer hospital visits.
In America, for the approximately 15 percent of asthma sufferers for whom the condition is severe, those who find themselves routinely missing work or school and in the emergency room more than once a year, inhalers and allergy medicines often are not enough to control symptoms and prevent flares.
“These are people whose lives are just miserable because they don’t know when the next flare will come or when the next time that they won’t be able to breathe will be,” said Dr. Robert Kruklitis, chief of pulmonary medicine at the Lehigh Valley Health Network in Allentown. He continued, “This gives people much more control over their life. They still take their asthma medications, but now they have asthma that is controlled.”
In America, asthma treatment costs exceed $10 billion a year and over half of that is spent on severe asthmatics, who make up only 10 percent of the asthma population. Doctors say, “Bronchial thermoplasty has given them a new weapon in the battle against severe asthma, and many patients call it life changing. But the procedure is expensive, costing around $20,000, and insurers have been reluctant to cover it. As a result, many people who need it are forced to go without it.”
“For those of us in the field who work with severe asthmatics and see how limited they are, it’s frustrating because we have this new therapy, we’ve seen it work, and the data says it works,” said Dr. Roy St. John, a pulmonary disease specialist at Columbus Pulmonary and Critical Care in Ohio. “But the big insurers have all denied it.”
At the advice of his allergy doctor, Mr Elder mentioned at the outset, recently enrolled in a study of bronchial thermoplasty being offered at Hershey Medical Center. The Medical Center, which is conducting the trial with funding from the maker of the device, is actively recruiting patients with moderate to severe asthma.
Mr Elder said, “It was absolutely painless and I was back to work the next day. I could tell a difference right away I feel like my lung capacity is improved and I can lift more. It’s too early to say that a big weight has been lifted from my shoulders for good, but the signs are positive so far.”
Excitement is somewhat tempered, however, because insurance companies are balking at having to pay for the procedure, which can cost $7,000 to $12,000, depending on the type of anesthesia used. Some patients have to pay significant portions of the cost themselves, which means not everyone who could benefit from it is able to afford it.
But three five year studies have already been completed. Many asthma specialists believe that insurers are taking a shortsighted approach. The one-time cost of $20,000, they say, is dwarfed by the tens of thousands of dollars in hospital bills and medication costs that a severe asthmatic can easily accumulate in a single year.
Dr Feller Kopman said, “Studies are under way to see if bronchial thermoplasty can replace medications in the future. People who breathe well all the time don’t appreciate what this means, I borrow a line from the American Lung Association all the time, when you can’t breathe, nothing else matters.”

Tuesday, 4 September 2012

COPD drug could be used to treat asthma patients


Patients with poorly controlled asthma are a step closer to a new treatment option, after Phase III data showed that Boehringer Ingelheim’s lung drug Tiotropium, significantly reduced exacerbations and improved both lung function and quality of life.
The phase III research, presented at the European Respiratory Society conference in Vienna, also showed adding the once daily drug could cut the risk of any asthma exacerbation by 31%.
Tiotropium, a long-acting inhaled bronchodilator commonly used to treat chronic obstructive pulmonary disease (COPD), is currently unlicensed for treating asthma.
Spiriva, which is known chemically as Tiotropium is delivered by the Respimat Soft Mist inhaler. The research was published in the New England Journal of Medicine. Tiotropium has comprehensive clinical trial data, demonstrating an extensive wealth of experience since its introduction almost 10 years ago and over 25million patient years of real life experience, to support the efficacy and safety profile.
However, there remain concerns over the drug’s risk in patients with heart disease. Last year an analysis published by the British Medical Journal, found that the use of Spiriva delivered in a mist form (via Respimat), was linked with a 52% increase in the risk of death.
Boehringer Ingelheim said, “It did not agree with the authors conclusion that there is an increased mortality risk for Spiriva Respimat in COPD, and that its risks and benefits were included in its label.”
The German drug maker went on to say, “There were also significant improvements in lung function, asthma control and asthma related quality of life, lending further weight to the case for its use in controlling the disease. The need for new and effective asthma treatments is great, because a significant proportion of patients remain symptomatic and may experience asthma exacerbations, despite current therapies.”
In two trials supported by the drug’s marketers, Boehringer Ingelheim and Pfizer, researchers recruited 912 patients with asthma already taking inhaled glucocorticoids and long-acting beta-agonists (LABAs).
Despite their drug regimen, all patients remained symptomatic and had at least one severe exacerbation within the past year. Researchers randomised these patients to receive either Tiotropium once daily or placebo alongside their usual treatment. These were administered using a soft mist inhaler.
The team found that after 24 weeks patients receiving Tiotropium went on average 282 days without a first exacerbation, 21% longer than those on placebo, who experienced an exacerbation within an average of 226 days. The effects were sustained over 24 hours. Adverse events were similar between treatment and placebo groups.
The researchers concluded that, “In patients with poorly controlled asthma despite treatment with inhaled glucocorticoids and LABAs, adding Tiotropium significantly reduced the risk of episodes of the worsening of asthma and asthma exacerbations, requiring treatment with systemic glucocorticoids and provided sustained bronchodilation.”

Monday, 3 September 2012

Olympians prove there’s life after asthma


Many would assume that after being diagnosed with asthma, you would not be able to enjoy exercise or sport to the extent that non asthma sufferers do. However whilst it is true that exercise is a trigger for asthma sufferers, does that have to mean an end to sporting activities for asthma sufferers and does it have to spell the end of any sporting hopes and dreams they may have.
Well not according to our Olympians who achieved so much success at the London 2012 Olympics. Bradley Wiggins, 2012 tour de France winner and Olympic gold medalist said, “It does sound quite bad if you are diagnosed with asthma and your natural instinct is to think that’s it. But there is better medication available now and I am an Olympic champion, the evidence is out there that you can succeed.”
That view was echoed by British marathon runner, Paula Radcliffe, who said, “I don’t really think asthma has affected my career, if anything it’s made me more determined to be successful and reach my maximum potential. If you learn to manage your asthma and take the correct medication, there’s no reason why you shouldn’t be the best.”
Another Olympian who didn’t let asthma hold her back was swimmer, Karen Pickering. She said, “I was diagnosed with asthma aged seven, which was when my doctor told me that swimming would help my asthma by strengthening my lungs. Despite exercise being one of my asthma triggers, I persevered and always kept an inhaler at the end of my lane while I trained and in my tracksuit pocket as I went up for my races. I went on to compete in four consecutive Summer Olympics and won Commonwealth and World Championship gold medals.”
Other athletes with asthma who took part in this year’s Olympics were: Rebecca Adlington (swimmer), Laura Trott (cycling), Jo Jackson (swimmer), Jo Pavey (runner), Alex Gregory (rower), Andrew Badderley (runner), Greg Rutherford (long jump), Michael Rimmer (runner), Adam Gemili (runner), Laura Weightman (runner), Euan Burton (Judo), Pete Reed (rower), Tom James (rower), Craig Bellamy (footballer), Mhairi Spence (pentathlete), and Ashley McKenzie (judo).
Further statistics from the United States Olympic Committee that back this up are that, 25% of athletes in the 2012 Team GB athletics squad have asthma. 20% of the entire British Olympic Squad at the 2004 Athens Olympic Games had asthma. Half of cross-country skiers and one quarter of aspiring Winter Olympians in general, have exercise-induced asthma.
According to the charity Asthma UK, “Often people with asthma are worried about exercising, because they think it will trigger their asthma symptoms. Actually, the majority of people with asthma should be able to take part in any type of activity or exercise they enjoy, as long as their asthma is under control. By starting with gentle walking or swimming it can be possible to go on to building your stamina and achieving great sporting feats.”
In fact, besides saying that asthmatics can exercise, the charity goes on to say, “Eight out of ten people with asthma aren’t doing enough exercise, often because they’re worried it will trigger their symptoms. But actually exercise can help your asthma, so don’t let it hold you back!”
They continue, “Exercise can help improve your lung capacity, which will help you to manage your asthma better when you exercise, cope better with everyday chores, worry less about your asthma and give you the confidence to manage your condition. If you’re worried about starting to exercise, have a chat with your GP or asthma nurse first. They’ll be able to help you find the best type of exercise for you. Get them to check that your asthma is under control.”
So in conclusion asthma doesn’t have to stop asthmatics enjoying exercise or sport, as long as it is properly managed and controlled. If that’s good enough for Olympic gold medalists such as Bradley Wiggins then it certainly offers hope for the 5.4million asthma sufferers in the UK.

Wednesday, 21 December 2011

Christmas brings warnings for asthma and allergy sufferers

As the festive period is upon us, an expert allergist at the Gottlieb Memorial Hospital in Maywood, Ill, has issued a warning which could dampen the moods of many. Fresh Christmas trees, plants, air fresheners, perfumes, dust and nuts may trigger asthma attacks and allergic reactions according to Dr. Joseph Leija.
Dr. Leija has warned that there is a good chance of a trigger being created through things such as:  the dust on old boxes of decorations that have been stored away for probably almost a year, fresh Christmas trees, and the popular holiday houseplant the Poinsetta, which has become almost as widely known at Christmas as holly and ivy.

The allergist commented in a Loyola University Health System news release: “The dust from the boxes and on the decorations that have been packed away in dank basements or dusty attics is triggering reactions in my allergy and asthma patients”. He further went on to suggest methods of avoiding such problems. For instance he advised avoiding scented candles and oils, choosing an artificial tree as apposed to a real and fresh one, staying clear of fresh plants and flowers, be careful with the humidifier and keeping humidity to no more than 48 to 50 percent, and finally to store all decorations in plastic bins to help keep them dust-free.

If you are worried about Dr. Leija’s warnings, why not be prepared and help beat the Christmas blues. At Medical Specialists we offer a wide range of medications to help asthma and allergy sufferers, all at great prices. If you are suffering from asthma like symptoms, you should see your doctor immediately for a diagnosis. Your doctor is able to prescribe medication if he feels you have asthma. If you have already been prescribed an inhaler or have lost your inhaler or run out and cannot get a prescription immediately, we are able to supply you an inhaler to help your asthma symptoms. We now offer both blue (relievers) inhalers such as Ventolin and Salbutamol, and brown (preventers) inhalers such as Qvar Beclomethasone, Qvar Easi-Breathe, and Pulvinal Beclomethasone. If you suffer from hay fever or allergies we offer Loratadine tablets and Nasonex spray. Both of the aforementioned are available without the need for a prescription.